Global Labeled Peptides Market Insights, Forecast to 2028

Labeled Peptides with stable, non-radioactive isotopes are increasingly used for convenient detection in research. Isotope–labeled, or ‘heavy’ amino acids, are derived from natural amino acids by substitution of certain atoms (N, C, H) with their ‘heavy isotope’ variant. The most frequently substitutions are 12C by 13C (carbon-13), 14N by 15N (nitrogen-15), and 1H by 2H (deuterium).
Market Analysis and Insights: Global Labeled Peptides Market
Due to the COVID-19 pandemic, the global Labeled Peptides market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, (Arg)9, FAM-labeled accounting for % of the Labeled Peptides global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Protein Chemistry segment is altered to an % CAGR throughout this forecast period.
China Labeled Peptides market size is valued at US$ million in 2021, while the US and Europe Labeled Peptides are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Labeled Peptides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Labeled Peptides include Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein and Eurogentec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Labeled Peptides Scope and Segment
Labeled Peptides market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Labeled Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
(Arg)9, FAM-labeled
(Arg)9, TAMRA-labeled
Others
Segment by Application
Protein Chemistry
Immunology
Histochemistry
Others
By Company
Pepscan
JPT Peptide Technologies
PEPTIDE INSTITUTE
Merck
BIOSYNTAN GmbH
LifeTein
Eurogentec
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE